tradingkey.logo
tradingkey.logo
Search

Ekso Bionics Ord Shs

CHRN
Add to Watchlist
10.750USD
+0.590+5.81%
Close 11-06 16:00(ET)
1.57BMarket Cap
LossP/E TTM

About Ekso Bionics Ord Shs Company

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.

Ekso Bionics Ord Shs Profile

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of Ekso Bionics Ord Shs

Name
Name/Position
Position
Shareholding
Change
Mr. Raj Jegannathan
Mr. Raj Jegannathan
Chief Technology Officer
Chief Technology Officer
1.40M
--
Mr. Raj Jegannathan
Mr. Raj Jegannathan
Chief Technology Officer
Chief Technology Officer
1.40M
--
Mr. Wesley (Wes) Cummins
Mr. Wesley (Wes) Cummins
Chairman of the Board
Chairman of the Board
200.00K
--
Mr. William M. Clancy, CPA
Mr. William M. Clancy, CPA
Independent Director
Independent Director
200.00K
--
Mr. Douglas S. (Doug) Miller
Mr. Douglas S. (Doug) Miller
Independent Director
Independent Director
200.00K
--
Dr. Richard N. (Rich) Nottenburg, Ph.D.
Dr. Richard N. (Rich) Nottenburg, Ph.D.
Independent Director
Independent Director
200.00K
--
Mr. Andrew Cordell Schaap
Mr. Andrew Cordell Schaap
Director
Director
200.00K
--
Mr. Wesley (Wes) Cummins
Mr. Wesley (Wes) Cummins
Chairman of the Board
Chairman of the Board
200.00K
--
Mr. William M. Clancy, CPA
Mr. William M. Clancy, CPA
Independent Director
Independent Director
200.00K
--
Mr. Douglas S. (Doug) Miller
Mr. Douglas S. (Doug) Miller
Independent Director
Independent Director
200.00K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Raj Jegannathan
Mr. Raj Jegannathan
Chief Technology Officer
Chief Technology Officer
1.40M
--
Mr. Raj Jegannathan
Mr. Raj Jegannathan
Chief Technology Officer
Chief Technology Officer
1.40M
--
Mr. Wesley (Wes) Cummins
Mr. Wesley (Wes) Cummins
Chairman of the Board
Chairman of the Board
200.00K
--
Mr. William M. Clancy, CPA
Mr. William M. Clancy, CPA
Independent Director
Independent Director
200.00K
--
Mr. Douglas S. (Doug) Miller
Mr. Douglas S. (Doug) Miller
Independent Director
Independent Director
200.00K
--
Dr. Richard N. (Rich) Nottenburg, Ph.D.
Dr. Richard N. (Rich) Nottenburg, Ph.D.
Independent Director
Independent Director
200.00K
--

FAQs

Who are the top five shareholders of Ekso Bionics Ord Shs?

The top five shareholders of Ekso Bionics Ord Shs are: Mr. Raj Jegannathan

How many institutions hold shares of Ekso Bionics Ord Shs (CHRN)?

As of 2026Q2, 59 institutions hold shares of Ekso Bionics Ord Shs, with a combined market value of approximately 952.96K, accounting for 26.74% of the total shares. Compared to 2026Q1, institutional shareholding has increased by 504772.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.